CVX Chevron Corp. $CVX Company Overview Stock Message

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
CVX Chevron Corp. $CVX Company Overview

Stock Message Board Recent Posts http://investorshangout.com/search?q=CVX&...mp;yt0=Go!

Last Updated: 08/05/2015 23:06:30

Current Price and Quotes
Last Price 84.03
Previous Close 85.21 Open 85.44
Daily Range 83.87 - 86.00 52wk Range 84.68 - 129.53
Volume 11,254,620 Dividend 4.28
Average Vol (30d) 8,505,293 Net Dividend Yield 5.0934




Financials
Period Ending Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011
Total Revenue 200,494,000 220,156,000 230,590,000 244,371,000
Cost of Revenue 144,956,000 159,323,000 163,336,000 171,572,000
Gross Profit 55,538,000 60,833,000 67,254,000 72,799,000
Operating Expenses

Research and Development - - - -
Sales, General and Admin. 17,034,000 17,573,000 17,100,000 20,373,000
Non-Recurring Items 1,985,000 1,861,000 1,728,000 1,216,000
Other 16,793,000 14,186,000 13,413,000 12,911,000
Operating Income 19,726,000 27,213,000 35,013,000 38,299,000
Income From Continuing Operations

Add'l Income/Expense Items 4,378,000 1,165,000 4,430,000 1,972,000
Earnings Before Interest and Tax 31,202,000 35,905,000 46,332,000 47,634,000
Interest Expense - - - -
Earnings Before Tax 31,202,000 35,905,000 46,332,000 47,634,000
Income Tax 11,892,000 14,308,000 19,996,000 20,626,000
Minority Interest 69,000 174,000 157,000 113,000
Equity Earnings Unconsolidated Subsidiary 7,098,000 7,527,000 6,889,000 7,363,000
Net Income Cont. Operations 26,339,000 28,950,000 33,068,000 34,258,000
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 19,241,000 21,423,000 26,179,000 26,895,000
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 19,241,000 21,423,000 26,179,000 26,895,000

Recent News

CVX Chevron Corp. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=CVX&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/CVX/quote
Stock Chart http://www.otcmarkets.com/stock/CVX/chart
Company Info http://www.otcmarkets.com/stock/CVX/company-info
Recent News http://www.otcmarkets.com/stock/CVX/news
Financials http://www.otcmarkets.com/stock/CVX/financials
Filings and Disclosure http://www.otcmarkets.com/stock/CVX/filings
Short Sales http://www.otcmarkets.com/stock/CVX/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/CVX/insider-transactions
Research Reports http://www.otcmarkets.com/stock/CVX/research
Summary http://finance.yahoo.com/q?s=CVX
Historical Prices http://finance.yahoo.com/q/hp?s=CVX+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=CVX
Basic Chart http://finance.yahoo.com/q/bc?s=CVX+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=CVX+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=CVX+Headlines
Press Releases http://finance.yahoo.com/q/p?s=CVX+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=CVX+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=CVX+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=CVX+Industry
Major Holders http://finance.yahoo.com/q/mh?s=CVX+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=CVX+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=CVX+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=CVX
Balance Sheet http://finance.yahoo.com/q/bs?s=CVX
Cash Flow http://finance.yahoo.com/q/cf?s=CVX+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/CVX
Market Watch http://www.marketwatch.com/investing/stock/CVX
Bloomberg http://www.bloomberg.com/quote/CVX:US
Morningstar http://quotes.morningstar.com/stock/s?t=CVX
Bussinessweek http://investing.businessweek.com/research/st...ticker=CVX
Barchart http://www.barchart.com/quotes/stocks/CVX
OTC Short Report http://otcshortreport.com/index.php?index=CVX
Investopedia http://www.investopedia.com/markets/stocks/CVX/?wa=0
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 9

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 12

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 12

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 11

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 16

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 11

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 12

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 14

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Women Through the Gettysburg Salon Experience

Updated Category News Views 116

Reimagining Women's Spaces Through the Gettysburg Salon The Gettysburg Salon is a vibrant platform where women can express themselves creatively and engage in thought-provoking dialogues. This initiative began with three passionate individuals who envisioned a safe space for women to explore their identities, aspirations, and challenges through art and conversation. In a...

Continue Reading
Transforming Off-Road Adventures: Upfit UTV and OMI Innovation

Updated Category News Views 165

Transforming Off-Road Adventures: Upfit UTV and OMI Innovation Upfit UTV, a subsidiary of Fox Factory known for customizing high-performance vehicles, has joined forces with OMI, a leader in electric powertrain engineering. Together, they are redefining off-road adventures with their groundbreaking Fusion-Drive technology. This innovation not only elevates performance but...

Continue Reading
Investor Alert: AstraZeneca Faces Class Action Lawsuit Under SEC Laws

Updated Category News Views 278

Investor Alert Regarding AstraZeneca Securities Class Action Kahn Swick & Foti, LLC, founded by former Attorney General Charles C. Foti, Jr., is highlighting crucial information for investors in AstraZeneca PLC (NASDAQ: AZN) who may have incurred losses exceeding $100,000. The firm reminds those affected that they need to file lead plaintiff applications for their class...

Continue Reading
Important Class Action for GSK plc Investors: Know Your Rights

Updated Category News Views 208

GSK Faces Class Action Lawsuit: Key Information for Investors Levi & Korsinsky, LLP has announced a class action securities lawsuit involving GSK plc, a well-known pharmaceutical company traded on the NYSE under the ticker GSK. This lawsuit is particularly significant for investors who have been adversely affected during a specified period concerning the securities of...

Continue Reading
Denny’s Fundraiser for No Kid Hungry: Making a Difference

Updated Category News Views 435

Denny’s Annual Fundraiser for No Kid Hungry Returns Denny’s is excited to bring back its annual in-restaurant fundraiser to support No Kid Hungry, a national initiative focused on ending childhood hunger in the United States. This campaign will run for a designated period, allowing Denny's restaurants to make a meaningful difference by ensuring that children have...

Continue Reading